Ten-year data on 138 patients with endometrial carcinoma and postoperative vaginal brachytherapy alone: No need for external-beam radiotherapy in low and intermediate risk patients

Gynecologic Oncology

Volumn 107, Issue 3, 2007, Pages 541-548

  Roper B ^a   Astner, S T ^a   Heydemann Obradovic, A ^a   Thamm, R ^a   Jacob, V ^a   Holzel D ^b   Schmalfeldt, B ^a   Kiechle Bahat, M ^a   Hoss C ^c   Molls, M ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c Kreisklinik Ebersberg   (Germany)

Author keywords

Adjuvant treatment; Brachytherapy; Endometrial carcinoma; External beam radiotherapy; Intermediate risk; Locoregional control; Radiotherapy; Secondary primary; Survival

Indexed keywords

IRIDIUM 192; TAMOXIFEN;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; BREAST CANCER; CANCER STAGING; CANCER SURVIVAL; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; POSTOPERATIVE CARE; PRIORITY JOURNAL; RADIATION DOSE; RISK FACTOR; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; DISEASE-FREE SURVIVAL; ENDOMETRIAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; VAGINA;

EID: 36448956876     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2007.08.055     Document Type: Article

References (33)

1. Jemal A., Siegel R., Ward E., Murray T., Xu J., and Thun M.J. Cancer statistics, 2007. CA Cancer J Clin 57 1 (2007) 43-66
2. Alektiar K.M. When and how should adjuvant radiation be used in early endometrial cancer?. Semin Radiat Oncol 16 3 (2006) 158-163
3. Anderson P.R. The role of radiation therapy in locally advanced endometrial cancer. Semin Radiat Oncol 16 3 (2006) 152-157
4. Lukka H., Chambers A., Fyles A., Thephamongkhol K., Fung-Kee-Fung M., Elit L., et al. Adjuvant radiotherapy in women with stage I endometrial cancer: a systematic review. Gynecol Oncol 102 2 (2006) 361-368
5. Aalders J., Abeler V., Kolstad P., and Onsrud M. Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients. Obstet Gynecol 56 4 (1980) 419-427
6. Keys H.M., Roberts J.A., Brunetto V.L., Zaino R.J., Spirtos N.M., Bloss J.D., et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 92 3 (2004) 744-751
7. Creutzberg C.L., van Putten W.L., Koper P.C., Lybeert M.L., Jobsen J.J., Warlam-Rodenhuis C.C., et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet 355 9213 (2000) 1404-1411
8. Creutzberg C.L., van Putten W.L., Koper P.C., Lybeert M.L., Jobsen J.J., Warlam-Rodenhuis C.C., et al. Survival after relapse in patients with endometrial cancer: results from a randomized trial. Gynecol Oncol 89 2 (2003) 201-209
9. Corn B.W., Lanciano R.M., D'agostino R., Kiggundu E., Dunton C.J., Purser P., et al. The relationship of local and distant failure from endometrial cancer: defining a clinical paradigm. Gynecol Oncol 66 3 (1997) 411-416
10. Sorbe B., Straumits A., and Karlsson L. Intravaginal high-dose-rate brachytherapy for stage I endometrial cancer: a randomized study of two dose-per-fraction levels. Int J Radiat Oncol Biol Phys 62 5 (2005) 1385-1389
11. Eltabbakh G.H., Piver M.S., Hempling R.E., and Shin K.H. Excellent long-term survival and absence of vaginal recurrences in 332 patients with low-risk stage I endometrial adenocarcinoma treated with hysterectomy and vaginal brachytherapy without formal staging lymph node sampling: report of a prospective trial. Int J Radiat Oncol Biol Phys 38 2 (1997) 373-380
12. Fanning J. Long-term survival of intermediate risk endometrial cancer (stage IG3, IC, II) treated with full lymphadenectomy and brachytherapy without teletherapy. Gynecol Oncol 82 2 (2001) 371-374
13. Alektiar K.M., Venkatraman E., Chi D.S., and Barakat R.R. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer. Int J Radiat Oncol Biol Phys 62 1 (2005) 111-117
14. Weiss E., Hirnle P., Arnold-Bofinger H., Hess C.F., and Bamberg M. Adjuvant vaginal high-dose-rate afterloading alone in endometrial carcinoma: patterns of relapse and side effects following low-dose therapy. Gynecol Oncol 71 1 (1998) 72-76
15. MacLeod C., Fowler A., Duval P., D'Costa I., Dalrymple C., Firth I., et al. High-dose-rate brachytherapy alone post-hysterectomy for endometrial cancer. Int J Radiat Oncol Biol Phys 42 5 (1998) 1033-1039
16. Anderson J.M., Stea B., Hallum A.V., Rogoff E., and Childers J. High-dose-rate postoperative vaginal cuff irradiation alone for stage IB and IC endometrial cancer. Int J Radiat Oncol Biol Phys 46 2 (2000) 417-425
17. Cengiz M., Singh A.K., and Grigsby P.W. Postoperative vaginal brachytherapy alone is the treatment of choice for grade 1-2, stage IC endometrial cancer. Int J Gynecol Cancer 15 5 (2005) 926-931
18. Jolly S., Vargas C., Kumar T., Weiner S., Brabbins D., Chen P., et al. Vaginal brachytherapy alone: an alternative to adjuvant whole pelvis radiation for early stage endometrial cancer. Gynecol Oncol 97 3 (2005) 887-892
19. Solhjem M.C., Petersen I.A., and Haddock M.G. Vaginal brachytherapy alone is sufficient adjuvant treatment of surgical stage I endometrial cancer. Int J Radiat Oncol Biol Phys 62 5 (2005) 1379-1384
20. Sobin L.H., and Wittekind C. TNM classification of malignant tumors. International Union Against Cancer. 6th ed. (2002), Wiley-Liss, New York
21. Nag S., Erickson B., Parikh S., Gupta N., Varia M., and Glasgow G. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the endometrium. Int J Radiat Oncol Biol Phys 48 3 (2000) 779-790
22. Pötter R., van Limbergen E., and Wambersie A. Intraluminal brachytherapy: definition of concepts, doses and volumes for reporting. In: Gerbaulet A., Pötter R., Mazeron J.J., Meertens H., and van Limbergen E. (Eds). The GEC ESTRO handbook of brachytherapy (2002), ACCO, Leuven 181-193
23. Briet J.M., Hollema H., Reesink N., Aalders J.G., Mourits M.J., ten Hoor K.A., et al. Lymphvascular space involvement: an independent prognostic factor in endometrial cancer. Gynecol Oncol 96 3 (2005) 799-804
24. Hogberg T., Fredstorp-Lidebring M., Alm P., Baldetorp B., Larsson G., Ottosen C., et al. A prospective population-based management program including primary surgery and postoperative risk assessment by means of DNA ploidy and histopathology. Adjuvant radiotherapy is not necessary for the majority of patients with FIGO stage I-II endometrial cancer. Int J Gynecol Cancer 14 3 (2004) 437-450
25. Creutzberg C.L., van Putten W.L., Warlam-Rodenhuis C.C., van den Bergh A.C., de Winter K.A., Koper P.C., et al. Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: the Postoperative Radiation Therapy in Endometrial Carcinoma Trial. J Clin Oncol 22 7 (2004) 1234-1241
26. Rittenberg P.V., Lotocki R.J., Heywood M.S., and Krepart G.V. Stage II endometrial carcinoma: limiting post-operative radiotherapy to the vaginal vault in node-negative tumors. Gynecol Oncol 98 3 (2005) 434-438
27. Creutzberg C.L., van Putten W.L., Koper P.C., Lybeert M.L., Jobsen J.J., Warlam-Rodenhuis C.C., et al. The morbidity of treatment for patients with Stage I endometrial cancer: results from a randomized trial. Int J Radiat Oncol Biol Phys 51 5 (2001) 1246-1255
28. Aalders J.G., and Thomas G. Endometrial cancer-revisiting the importance of pelvic and para aortic lymph nodes. Gynecol Oncol 104 1 (2007) 222-231
29. Mohan D.S., Samuels M.A., Selim M.A., Shalodi A.D., Ellis R.J., Samuels J.R., et al. Long-term outcomes of therapeutic pelvic lymphadenectomy for stage I endometrial adenocarcinoma. Gynecol Oncol 70 2 (1998) 165-171
30. Zhu L., Le T., Popkin D., and Olatunbosun O. Quality-of-life analysis in the management of endometrial cancer. Am J Obstet Gynecol 192 5 (2005) 1388-1390
31. McCormick T.C., Cardenes H., and Randall M.E. Early-stage endometrial cancer: is intravaginal radiation therapy alone sufficient therapy?. Brachytherapy 1 2 (2002) 61-65
32. Macdonald O.K., Sause W.T., Lee R.J., Lee C.M., Dodson M.K., Zempolich K., et al. Adjuvant radiotherapy and survival outcomes in early-stage endometrial cancer: a multi-institutional analysis of 608 women. Gynecol Oncol 103 2 (2006) 661-666
33. Lee C.M., Szabo A., Shrieve D.C., Macdonald O.K., and Gaffney D.K. Frequency and effect of adjuvant radiation therapy among women with stage I endometrial adenocarcinoma. JAMA 295 4 (2006) 389-397